An FDA panel is reviewing seven peptides for potential medical use, despite concerns over safety and effectiveness. The peptides, which are essentially the building blocks of proteins, have become a growing wellness trend, with some proponents claiming they can help with issues such as muscle recovery and anti-aging.

Peptide Proponents and Critics

Supporters of peptides, including podcaster Joe Rogan and wellness influencers, claim that the substances are safe and effective. However, critics, including FDA scientists and medical experts, argue that there is not enough data to support the use of peptides for medical purposes. They also point out that the peptides being sold online are often imperfect synthetics and are taken at doses much higher than any peptides found in the body, raising the risk of allergic reactions and other harms.

The FDA panel will review the seven peptides, including BPC-157, KPV, TB-500, and MOTs-C, and vote on whether they should be allowed to be compounded by pharmacies. The meeting will also include opportunities for public comment and discussion.

Regulatory Background

The FDA has previously warned about the risks of injecting peptides like BPC-157 and TB-500, which are considered doping substances by international sports authorities. The agency has also expressed concerns about the lack of data on the safety and effectiveness of peptides and the potential risks of contamination, allergic reactions, and quality control issues.

Original reporting: Dallas TX News (HLL/CB) — read the source article.